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Abstract - Due to the role of interleukin-2 (IL-2) in the mediation of immune response, this cytokine has been
used in the treatment of some types of cancer and infectious diseases. However, relatively high levels of this
cytokine are required to achieve significant activity. The aim of this work was to study a culture medium
composition designed to increase the production of IL-2 by suspended murine EL-4 cells. The cultivations
were carried out aiming at producing IL-2 in stirred bioreactors. The effects of concentration of glutamine,
phorbol-12-myristate-13-acetate (PMA), concanavalin A (Con A), Pluronic F68, and fetal calf serum (FCS)
on cell viability and IL-2 production were evaluated. PMA alone was more efficient in IL-2 production than it
was in association with Con A. The maximum IL-2 production was around 162 ng/mL with 856 ng/mL PMA
and 1.45% (v/v) FCS.
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INTRODUCTION
The administration of high-dose recombinant
interleukin-2 (IL-2) to humans has been reported to 
mediate the regression of some types of cancer, such
as kidney cancer, melanomas and non-Hodgkin´s
lymphoma (Rosenberg et al., 1985a; 1985b;
Weinreich and Rosenberg, 2002). Although IL-2 has
no direct effect on tumor cells, this cytokine has the
ability to expand lymphocytes with anti-tumor
activity in vivo. However, toxicity and adverse side
effects, such as vascular leak syndrome and elevated
serum cortisol levels (Stites et al., 1994), occur at 
pharmacological IL-2 dosages, which vary from 
picomolar to nanomolar concentrations in serum
(Fehniger et al., 2002). These effects should be 
evaluated more extensively, which can be initially
done through experiments with animal models, such
as mice.
Although IL-2 is naturally secreted in low 
quantities by naturally activated T lymphocytes
(Walsh and Headon, 1994), the culture of other cell 
lines, such as tumor and recombinant cells, can result
in higher IL-2 concentrations. A lymphoblast cell 
line isolated from a murine thymus tumor, referred to
as EL-4 (Farrar et al., 1980), has been extensively 
employed to study the production of IL-2 in vitro.
The IL-2 produced by those cells can be utilized in 
tests in vivo, using mice as animal models, since it is
biochemically and biologically indistinguishable
from that produced by healthy mice (Chang et al.,
1985).
It has been shown that phorbol-12-myristate-13-
acetate (PMA) and/or concanavalin A (Con A)
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Experimental Design stimulate EL-4 cells to produce high levels of the 
cytokine in the culture supernatants (Farrar et al.,
1980; Lasek et al., 1989), mimicking the effects of a
specific antigen on the thymoma cells. The effects of
other cell stimulants, such as vomitoxin,
cycloheximide (Dong et al., 1994), and vitamin E 
succinate (Yu et al., 1996) on IL-2 production by
EL-4 cells have also been evaluated. However, few
data are available on the effects of medium
components and their metabolites on EL-4 cell 
growth as well as on IL-2 production by those cells.
The effects of the variables glutamine
concentration, PMA concentration, percentage of
Pluronic F68 (w/v) and percentage of FCS (v/v), and
initial cell concentration were studied to evaluate the 
influence of culture medium composition and
inocula concentration on cell growth, viability, and 
IL-2 production after 40 hours. These effects were 
analysed employing a 25-1 factorial experimental
design with three replicates at the center point in a
total of 19 experiments, employing RPMI-1640
supplemented with 50 ?g/mL of gentamicin as the 
minimal media. The variables whose effects had
statistical significance were studied in a second 
experimental design. A third experimental design was
used to evaluate the effects of Con A on IL-2 production.
In this work, the effects of glutamine
concentration (carbon and nitrogen source), PMA 
and Con A concentrations (IL-2 production
stimulants), percentage of Pluronic F68 (an additive 
protecting cells against shear damage), percentage of
FCS (additional nutrients), and cell inocula were 
evaluated, aiming at a high level of production of IL-
2. The experimental design strategy, which has not
as yet been extensively applied to mammalian cell
culture, was used.
Determination of Cell Concentration and 
Viability
Cell concentration was determined by optical 
microscopy with the use of a hemocytometer. Viable
cells were determined by Trypan Blue exclusion
(Freshney, 1994).
MATERIALS AND METHODS
Materials
Determination of Interleukin-2 Concentration 
EL-4 lymphoblasts were kindly donated by Dr.
João Santana da Silva (Departamento de Imunologia,
Faculdade de Medicina, Universidade de São Paulo, 
Ribeirão Preto, SP - Brazil). Cells were cultured in 
RPMI-1640 medium containing gentamicin (50 
?g/mL) and different concentrations of L-glutamine,
PMA, type IV-S Con A, Pluronic F68 (Sigma
Chemical Co.), FCS (Cultilab), and dimethylsulfoxide
(Merck). Medium compositions employed in the 
different experiments are described in Tables 1, 2, 
and 3. The cells were grown in 25 cm² tissue culture
polystyrene flasks (Corning) and cultured for IL-2
production in six-well polystyrene culture plates 
(Costar). The cells were incubated for 40 h at 37°C
in a humidified chamber with 5% CO2.
IL-2 concentration was determined by 
immunoassay, employing the M2000 Mouse IL-2 
Quantikine M kit (R&D Systems). The assays were
conducted essentially as suggested by the 
manufacturer. Briefly, all reagents were brought to
room temperature and 50?L of assay diluents were
added to each well of a 96-well microplate coated
with polyclonal antibody specific to mouse IL-2.
Fifty ?L aliquots of standards, controls, and 
adequately diluted samples were added to each well.
The microplate was gently shaken, covered, and 
incubated for two hours at room temperature. The
wells were vacuumed and washed five times with the
buffer provided by the manufacturer. Following this
procedure, 100 ?L of a solution containing an 
antibody against mouse IL-2 conjugated to 
horseradish peroxidase were added to each well. The
plate was covered, incubated for two hours at room 
temperature, aspirated, and washed five times.
Subsequently, 100 ?L of substrate (stabilized 
hydrogen peroxide) were added to each well and the
plate was incubated at room temperature for 30 
minutes, after which the reaction was interrupted by 
the addition of 100 ?L of diluted hydrochloric acid
solution. The optical density at 450 nm was read on a
Preparation of the Inocula 
EL-4 cells were grown in RPMI-1640 medium
(detailed composition described by Freshney, 1994)
supplemented with 10% (v/v) FCS to obtain the
inocula. When 60 to 80% of the culture flask was 
occupied, cells were subcultured. When sufficient
cell concentration was obtained, cell suspension was
centrifuged and the pellet was suspended in RPMI-
1640 medium without FCS.
Brazilian Journal of Chemical Engineering
The Effect of Medium Composition on Interleukin-2 Production    167 
Labsystems Multiskan MS after 30 minutes, with the 
correction wavelength set at 540 nm to correct for 
optical imperfections in the plate. 
RESULTS AND DISCUSSION
Effects of Cell, Glutamine, PMA, Pluronic F68, 
and FCS Concentrations on Cell Viability and IL-
2 Production
The influence of PMA, glutamine, and cell 
concentrations, and percentage of Pluronic F68 (w/v)
and percentage of FCS (v/v) on cell viability and IL-
2 production after 40h incubation were studied using
a 25-1 factorial experimental design with three 
replicates at the center point. The minimum medium
(RPMI-1640 containing 50 ?g/mL of gentamicin)
was supplemented with the above-mentioned
compounds. Table 1 shows the experimental design
with the ranges for each variable and the results
obtained. IL-2 concentration varied from 0 to 98
ng/mL, showing the importance of culture medium
formulation for large-scale production of IL-2. 
Larger IL-2 concentrations were obtained when the
initial cell concentration was 1.0*106 cell/mL.
Experiments 14 and 16 showed the best results for
IL-2 production.
The contrasts of the independent variables on the 
response variables (shown in Figure 1) were 
calculated using the software Statistica. The 
variables that were statistically significant at a
confidence level of 95% on IL-2 production were 
PMA and cell concentrations and percentage of FCS. 
An increase in these variables caused an increase in 
IL-2 concentration. This result was expected, since
PMA is a stimulant of IL-2 production and FCS is an 
essential component of the cell culture, stimulating
cell growth and other cell activities through 
hormones and growth factors.
Table 1: 25-1 factorial experimental design with three replicates of the center point. The minimum
medium formulation was RPMI-1640 supplemented with 50 ?g/mL of gentamicin.
Exp.
PMA
(ng/mL)
Pluronic
F68
(%)
FCS
(%)
Glutamine
(g/L)
Initial cell
concentration
(cells/mL)
IL-2
concentration
(ng/mL)
Cell
viability
(%)
1 10 0.0 0 0.60 0.10*106 0.10 100
2 100 0.0 0 0.30 0.10*106 1.13 75
3 10 0.2 0 0.30 0.10*106 3.64 77
4 100 0.2 0 0.60 0.10*106 9.61 60
5 10 0.0 10 0.30 0.10*106 6.75 75
6 100 0.0 10 0.60 0.10*106 13.20 62
7 10 0.2 10 0.60 0.10*106 12.62 68
8 100 0.2 10 0.30 0.10*106 15.96 61
9 10 0.0 0 0.30 1.00*106 0.00 63
10 100 0.0 0 0.60 1.00*106 0.89 71
11 10 0.2 0 0.60 1.00*106 3.08 69
12 100 0.2 0 0.30 1.00*106 28.89 71
13 10 0.0 10 0.60 1.00*106 27.39 62
14 100 0.0 10 0.30 1.00*106 66.24 48
15 10 0.2 10 0.30 1.00*106 11.88 69
16 100 0.2 10 0.60 1.00*106 97.99 52
17 55 0.1 5 0.45 0.55*105 39.69 50
18 55 0.1 5 0.45 0.55*105 56.62 56
19 55 0.1 5 0.45 0.55*105 42.78 57
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Figure 1: Main contrasts obtained for the 25-1 factorial experimental design on cell viability and IL-2 
concentration. The minimum medium formulation was RPMI-1640 supplemented with 50 ?g/mL of
gentamicin. * indicates that the variable is statistically significant at a confidence level of 95%. 
However, increases in PMA, FCS, and cell 
concentrations resulted in a significant reduction in
cell viability at a confidence level of 95%. Since 
phorbol esters are thought to promote cell survival 
and protection against cell death by activation of 
PKC-dependent signaling pathways, the decrease in 
cell viability with the increase in PMA concentration
should be attributed to a possible inhibitory effect of 
this compound on the interaction of IL-2 with its 
receptor on the cell surface (Farrar et al., 1980).
The paradoxal effect of FCS on cell viability may
be attributed to an indirect effect of the long culture 
time, since FCS is not expected to decrease cell
viability. After the 40-hour culture period, the
culture medium was probably depleted of nutrients
and already accumulating toxic metabolites such as 
ammonium and lactate, which could be present at
higher concentrations in the samples originally
containing more serum. However, this hypothesis 
was not tested.
Pluronic F68 and glutamine did not have a 
significant effect on cell viability and IL-2
production in the concentration ranges studied. Since 
Pluronic F68 is an agent that protects cells against
shear damage, its concentration in the culture 
medium was maintained at 0.2% in the following
experiments, whereas glutamine concentration was
fixed at 0.3 g/L to minimize costs. 
Generally, cultures initiated with 1.0*106 cell/mL
inocula yielded higher levels of IL-2 than those 
starting at 1.0*105 cell/mL. This finding was more
evident when large concentrations of PMA (505
ng/mL) were used. In this circumstance, the increase
in IL-2 formation was closely associated with the 
abbreviation of the cell growth lag phase. Figure 2
summarizes the behavior of a cell culture starting at
1.0*106 cell/mL and shows that IL-2 formation is 
partially associated with cell growth beginning 
during the lag phase, which lasts around 30 hours 
and can be related to the maintenance of the cells in
the G1 phase by PMA. The larger cytokine
production before cell doubling is in accordance with 
in vivo behavior, since the IL-2 released by T CD4+
cells peaks from 8 to 12 hours after cell activation 
(Abbas et al., 2000). 
Despite inducing high IL-2 production, increasing
the inoculum concentration resulted in diminished
cell viability, possibly due to the fast consumption of 
substrates with the rapid formation of deleterious 
compounds. In response to these results, and in an 
attempt to reach a compromise between cell viability 
and IL-2 formation, cell concentration was 
maintained at 1.0*106 cell/mL in the subsequent
experiments.
Extended Studies of the Effects of PMA
Concentration and Percentage of FCS on Cell 
Growth, Viability, and IL-2 Production 
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Despite the fact that high PMA concentration 
decreased cell viability, the concentration range was 
extended to 10 to 1000 ng/mL in this set of 
experiments, aiming at higher IL-2 production. FCS
range was maintained at 0 to 10% (v/v), due to the 
fact that higher FCS concentration increases
significantly the cost of culture medium and
interferes with the purification stage. A 2² factorial
experimental design with four axial center points and
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four replicates at the center point, in a total of 12 
experiments, was employed. The results are shown
in Table 2. 
The highest IL-2 concentration, around 162
ng/mL, was obtained in experiment 2 in a medium
containing 856 ng/ml of PMA and 1.45% of FCS.
The total cell concentration after 40 h varied only
from 0.88*106 to 1.74*106 cell/mL, which can be 
related to the PMA effect of arresting cells in the G1
phase of cell growth. Cell viability varied from 31 to 
60%, with a central points average of 36.3 ? 2.1%.
Figure 3 shows the effects of the independent
variables on IL-2 concentration and cell viability.
PMA and FCS concentrations (linear terms) were
statistically significant at a confidence level of 95% 
in IL-2 amounts released by EL-4 cells. The increase
in PMA concentration in the culture medium results
in an increase in IL-2 production, whilst the increase
in percentage of FCS results in a decrease in IL-2
concentration in the cell cultures. In the previously
used experimental design, FCS concentration had 
shown a positive effect on IL-2 concentration. The 
interaction term was significant at a confidence level 
of 89%, revealing a negative effect on IL-2
production. The p-value showed that quadratic terms
were not statistically significant. 
There was a slight decrease in cell viability with
the increase in PMA concentration at a confidence
level of 90%. The increase in FCS concentration 
again showed a negative effect (confidence level of 
95%), which may be due to the observation of cell 
viability only after 40 h. The quadratic terms were
statistically significant (confidence level of 95%),
but the interaction term was not.
Supplementary experiments showed that low 
concentrations of FCS in the culture medium are 
required for the production of more elevated levels
of IL-2 (data not shown). In the absence of FCS,
there was a lower level of IL-2 production than that 
obtained in these experiments, even for 
concentrations of PMA up to 2000 ng/mL.
Although it is not possible to directly compare the 
IL-2 production data presented herein to data from 
the literature, the behavior of EL-4 cells obeyed the
same patterns as that reported by other authors 
(Farrar et al., 1980; Lasek et al., 1989; Dong et al.,
1994; Yu et al., 1996). The direct comparison of IL-2 
concentration is not recommended because most of
the previous work discusses IL-2 production in terms 
of activity assessed by bioassays, and not in terms of
concentration (ng/mL) as in the immunoassays
carried out in this work. However, Farrar et al.
(1980) achieved 5462.4 units of IL-2 activity per
milliliter with EL-4 cells, which would be equivalent 
to around 27 ng/mL according to the international 
standard of NIBSC/WHO (National Institute for 
Biological Standards and Control/World Health
Organization). In our study, up to 162 ng/mL of IL-2
accumulated in the culture medium; however, the IL-
2 bioactivity was not determined. 
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Figure 2:  Evaluation of cell concentration, cell viability, and IL-2 production during culture
of 4.5*105 cells/mL in RPMI-1640 supplemented with 5 % (v/v) FCS, 505 ng/mL PMA,
0.2 % (w/v) Pluronic F68, 0.3 g/L glutamine, and 50 ?g/mL of gentamicin.
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Table 2: 22 factorial experimental design with four axial center points and four replicates of the
center point. The minimum medium formulation was RPMI-1640 supplemented with 50 ?g/mL
of gentamicin. Percentage of Pluronic F68 and glutamine and cell concentrations were
maintained constant at 0.2%, 0.3 g/L, and 1.0*106 cells/mL, respectively.
Exp.
PMA
(ng/mL)
FCS
(%)
IL-2
concentration
(ng/mL)
Final cell
concentration
(cells/mL)
Final cell
viability
(%)
1 154 1.45 123.83 1.57*106 50
2 856 1.45 162.25 1.31*106 60
3 154 8.55 75.44 1.26*106 30
4 856 8.55 94.68 1.08*106 39
5 10 5.00 67.33 1.54*106 49
6 1000 5.00 134.41 0.88*106 46
7 505 0.00 117.18 1.22*106 52
8 505 10.00 81.92 1.43*106 31
9 505 5.00 106.62 1.42*106 38
10 505 5.00 107.27 1.16*106 37
11 505 5.00 110.67 1.74*106 37
12 505 5.00 100.79 1.24*106 33
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Figure 3: Effects obtained for the 22 factorial experimental design on cell viability and IL-2 concentration.
The minimum medium formulation was RPMI-1640 supplemented with 50 ?g/mL of gentamicin. Initial
cell concentration, percentage of Pluronic F68, and glutamine concentration were maintained constant
at 1.0*106 cells/mL, 0.2%, and 0.3 g/L, respectively. * indicates that the variable is statistically
significant at a confidence level of 95%. ** indicates that the variable is statistically significant
at a confidence level of 90%. *** indicates that the variable is statistically significant at a
confidence level of 89%. L refers to linear and Q refers to quadratic effects. 
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Evaluation of the Synergetic Effects of Con A
with PMA and FCS 
The effect of another stimulant, Con A, in
association with PMA, on IL-2 production was
evaluated based on the observations of Lasek et al.
(1989), who obtained high IL-2 activity with a 
medium containing both stimulants simultaneously.
A 23 experimental design with six axial center points 
and four replicates at the center point was employed.
Based on the results obtained by Lasek et al. (1989),
the selected range of Con A concentration was 0 to 
2.5 ?g/mL. The PMA concentration range was 
extended to 500 to 2000 ng/mL and percentage of FCS 
was reduced to 0 to 3% (v/v), because the previous
experimental design indicated that an increase in PMA 
concentration and a reduction in percentage of FCS 
could result in higher IL-2 production.
The results obtained in this set of experiments for 
IL-2 concentration and cell viability were below 
those achieved previously when only PMA and FCS
effects were evaluated (Table 3). The maximum cell
concentration attained was 1.83*106 cell/mL. The 
statistical treatment of the data resulted in the effects 
shown in Figure 4. 
The variation in PMA concentration from 500 to 
2000 ng/mL did not have a significant effect on IL-2 
production. An increase in Con A and FCS 
concentrations brought about a similar increase of 
9.45 and 8.50 ng/mL, respectively, in IL-2
concentration. Interaction terms did not show 
significance at a confidence level of 90%, showing 
that these stimulants did not have a synergetic effect
on IL-2 production by this cell line for the 
concentration ranges employed.
Concerning cell viability, the effect of PMA 
concentration and the effect of the interaction 
between PMA and FCS had statistical significance at
a confidence level of 90%. The increase in PMA
concentration caused an increase in cell viability, and 
the interaction term showed a negative effect on this 
variable.
Table 3: 2³ factorial experimental design with six axial center points and four replicates of the
center point. The minimum medium formulation was RPMI-1640 supplemented with 50 ?g/mL
of gentamicin. Percentage of Pluronic F68 and glutamine and cell concentrations were
maintained constant at 0.2%, 0.3 g/L, and 1.0*106 cells/mL, respectively.
Exp.
PMA
(ng/mL)
Con A 
(?g/mL)
FCS
(%)
IL-2
concentration
(ng/mL)
Final cell
concentration
(cells/mL)
Final cell
viability
(%)
1 804 0.51 0.61 72.22 1.31*106 18
2 1696 0.51 0.61 66.78 1.44*106 29
3 804 1.99 0.61 90.03 1.40*106 13
4 1696 1.99 0.61 83.14 1.43*106 29
5 804 0.51 2.39 77.04 1.56*106 19
6 1696 0.51 2.39 74.24 1.28*106 22
7 804 1.99 2.39 77.92 1.71*106 22
8 1696 1.99 2.39 79.83 1.56*106 25
9 500 1.25 1.50 72.22 1.51*106 10
10 2000 1.25 1.50 76.40 1.37*106 37
11 1250 0.00 1.50 80.47 1.51*106 20
12 1250 2.50 1.50 94.63 1.46*106 21
13 1250 1.25 0.00 45.36 0.95*106 30
14 1250 1.25 3.00 81.74 1.51*106 23
15 1250 1.25 1.50 76.27 1.24*106 26
16 1250 1.25 1.50 81.74 1.83*106 19
17 1250 1.25 1.50 87.86 1.31*106 26
18 1250 1.25 1.50 77.04 1.58*106 24
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Figure 4: Effects obtained for the 2³-factorial experimental design. The minimum medium formulation
was RPMI-1640 supplemented with 50 ?g/mL of gentamicin. Cell concentration, percentage of Pluronic
F68, and glutamine concentration were maintained constant at 1.0*106 cells/mL, 0.2%, and 0.3 g/L
respectively. * indicates that the variable is statistically significant at a confidence level of 90%. 
CONCLUSIONS
From the results obtained it can be observed that 
glutamine concentration and percentage of Pluronic
F68 did not have significant effects on IL-2 
production and cell viability. The highest IL-2 
concentration occurred, in general, for an initial cell
concentration of 1.0*106 cell/mL. The independent 
variables that most influenced IL-2 production were 
PMA concentration and percentage of FCS. An IL-2 
concentration of 162 ng/mL was attained when 856
ng/mL PMA and 1.45% (v/v) FCS were present in
the culture medium. The addition of PMA in 
association with Con A was less efficient than the 
addition of PMA alone. These stimulants did not 
have a synergetic effect in the concentration ranges 
studied.
REFERENCES
Abbas, A.K., Lichtman, A.H. and Pober, J.S., 
Cellular and Molecular Immunology. 4th edition,
W. B. Saunders, Philadelphia, 553 p. (2000).
Chang, A.E., Lotze, M.T., Ames, R.S., Roth, J.A. 
and Rosenberg, S.A., A Large Scale Method of
Separating Multiple Lymphokines Secreted by 
the Murine EL-4 Thymoma. Journal of 
Immunopharmacology, 7 (1), 17-31 (1985).
Dong, W., Azcona-Oliveira, J.I., Brooks, K.H., Linz, 
J.E. and Pestka, J.J., Elevated Gene Expression
and Production of Interleukins 2, 4, 5 and 6
during Exposure to Vomitoxin (Deoxynivalenol)
and Cycloheximide in the EL-4 Thymoma.
Toxicology and Applied Pharmacology, 127,
282-290 (1994).
Farrar, J.J., Fuller-Farrar, J., Simon, P.L., Hilfiker,
M.L., Stadler, B.M. and Farrar, W.L., Thymoma
Production of T Cell Growth Factor (Interleukin-
2). Journal of Immunology, 125, 2555-2558
(1980).
Fehniger, T.A., Cooper, M.A. and Caligiuri, M.A.,
Interleukin-2 and Interleukin-15: Immunotherapy
for Cancer. Cytokine & Growth Factor Reviews, 
13, 169-183 (2002).
Freshney, R.I., Culture of Animal Cells – A Manual 
of Basic Technique. 3rd edition, Wiley-Liss, New 
York, 486 p. (1994).
Lasek, W., Steer, S., Clothier, R. and Balls, M., The
Stimulation of EL-4 Cells to Produce Interleukin-
2 and Its Potential Use in Immunocytotoxicity
Testing. Immunopharmacology and Immunotoxicology,
11 (2-3), 379-396 (1989).
Rosenberg, S.A., Mule, J.J., Spiess, P.J., Reichert,
C.M. and Schwarz, S.L., Regression of
Established Pulmonary Metastases and
Subcutaneous Tumor Mediated by the Systemic
Administration of High-dose Recombinant Interleukin
2. Journal of Experimental Medicine, 161 (5),
1169-1188 (1985a).
Brazilian Journal of Chemical Engineering
Rosenberg, S.A., Lotze, M.T., Muul, L.M., Leitman,
S., Chang, A.E., Ettinghausen, S.E., Matory, 
Y.L., Skibber, J.M., Shiloni, E., Vetto, J.T., 
Seipp, C.A., Simpson, C. and Reichert, C.M., 
The Effect of Medium Composition on Interleukin-2 Production    173 
Observations on the Systemic Administration of 
Autologous Lymphokine-activated Killer Cells 
and Recombinant Interleukin-2 to Patients with
Metastatic Cancer. New England Journal of 
Medicine, 313 (23), 1485-1492 (1985b).
Stites, D.P., Terr, A.I. and Parslow, T.G., Basic and
Clinical Immunology. 8th edition, Prentice-Hall
International, Norwalk, 870 p. (1994).
Walsh, G. and Headon, D., Protein Biotechnology.
John Wiley & Sons, Chichester, 371 p. (1994).
Weinreich, D.M. and Rosenberg, S.A., Response Rates
of Patients with Metastatic Melanoma to High-dose
Intravenous Interleukin-2 after Prior Exposure to
Alpha-Interferon or Low-dose Interleukin-2. Journal
of Immunotherapy, 25 (2), 185-187 (2002).
Yu, W., Sanders, B.G. and Kline, K., Modulation of 
Murine EL-4 Thymic Lymphoma Cell
Proliferation and Cytokine Production by Vitamin
E Succinate. Nutrition and Cancer – An 
International Journal, 25, 137-149 (1996).
Brazilian Journal of Chemical Engineering Vol. 21,  No. 02,  pp. 165  - 173,  April - June  2004 
